Financial Health Assessment: HIDROSTAL (GB) LIMITED

1. Financial Health Score: B- (Provisional)

Explanation: Based on the available corporate and compliance data, Hidrostal (GB) Limited exhibits a healthy structural and regulatory profile. The company has a strong "corporate immune system" backed by a Swiss parent company and shows no external symptoms of distress (such as overdue filings or insolvency proceedings). However, because detailed financial metrics (the "blood work") are not provided in this dataset, a complete internal health check cannot be performed, and the score remains provisional.

2. Key Vital Signs

• Compliance Pulse (Filing Status): Strong. The company’s accounts and confirmation statements are not overdue. This indicates a regular, healthy administrative heartbeat. The company is breathing steadily from a regulatory standpoint, with no signs of the administrative asphyxiation that often precedes corporate failure.
• Corporate Lineage (Ownership Structure): Robust. The patient is securely tethered to a larger parent entity, Hidrostal Holding AG, which owns more than 75% of the shares. This acts as a powerful financial life-support system; if the UK entity experiences short-term cash flow illness, the Swiss parent can likely provide the necessary transfusion of capital.
• Capital Baseline (Share Capital): Nominal. The issued share capital stands at a modest £627. While this is a very low figure, it is a common anatomical feature of UK subsidiaries owned by overseas holding companies. Instead of relying heavily on share capital, these entities are typically funded via intercompany loans (the "intravenous drip" of corporate finance).
• Organ Longevity (Operating History): Established. Incorporated in 2006, the company has an 18-year operating history. This demonstrates an ability to survive multiple economic "flu seasons" (recessions and market downturns), suggesting a resilient underlying business model.
• Internal Diagnostics (Financial Figures): Absent. The critical blood work—cash flow, net current assets, and P&L reserves—is missing from this examination. Without these, we cannot measure the company's internal metabolic rate or financial stamina.

3. Diagnosis

Based on the external examination, Hidrostal (GB) Limited is an active, structurally sound entity operating as a localized arm of a wider international group. The absence of overdue filings, liquidation markers, or disqualification records for directors suggests a business that is functioning normally and is well-maintained.

However, the lack of published detailed financials presents a diagnostic blind spot. Because it is a "Group" category filer and a subsidiary of a foreign holding company, it files abbreviated or medium-exempt accounts at Companies House. This means the deepest layers of its financial health—true profitability, cash reserves, and debtor/creditor days—are kept hidden from the public bloodstream. The company appears outwardly healthy, but without the full financial statements, we cannot rule out internal stresses such as over-reliance on parent company loans or thin operating margins.

4. Recommendations

To move from a provisional assessment to a clean bill of financial health, the following steps should be taken:

1. Conduct a Full Blood Panel: Request full, unabridged financial statements directly from the company's leadership. You need to see the working capital (Current Assets minus Current Liabilities) and P&L reserves to truly gauge if the UK entity is self-sustaining or entirely dependent on the parent.
2. Check the Parent's Vitals: Because Hidrostal Holding AG provides the ultimate safety net, any comprehensive health check must include an assessment of the Swiss parent's financial wellness. If the parent falls ill, the UK subsidiary will almost certainly catch a cold.
3. Review Intercompany Balances: Examine the nature of the funding from Hidrostal Holding AG. If the UK company is heavily reliant on intercompany loans rather than share capital, check the repayment terms. A sudden demand for repayment from the parent could trigger a financial cardiac arrest in the UK entity.